Valuation: Revvity, Inc.

Market Cap 1.75TCr 1.57TCr 1.44TCr 1.31TCr 2.44TCr 1,66300Cr 2.49TCr 17TCr 6.91TCr 88TCr 6.57TCr 6.43TCr 2,75900Cr P/E 2026 *
66.2x
P/E 2027 * 54.9x
Enterprise Value 1.95TCr 1.75TCr 1.61TCr 1.46TCr 2.72TCr 1,85200Cr 2.77TCr 19TCr 7.69TCr 97TCr 7.32TCr 7.16TCr 3,07200Cr EV / Sales 2026 *
6.84x
EV / Sales 2027 * 6.31x
Free-Float
99.74%
Yield 2026 *
0.18%
Yield 2027 * 0.17%
1 day-5.30%
1 week-1.11%
1 month+5.33%
3 months+39.53%
6 months+81.13%
Current year+62.27%
1 week 155.81
Extreme 155.81
169.06
1 month 146.7
Extreme 146.7
169.06
Current year 81.22
Extreme 81.22
169.06
1 year 81.22
Extreme 81.22
169.06
3 years 81.22
Extreme 81.22
169.06
5 years 79.5
Extreme 79.5
203.16
10 years 45.35
Extreme 45.35
203.16
Manager TitleAgeSince
Chief Executive Officer 61 30/12/2019
Director of Finance/CFO 37 06/09/2022
Chief Tech/Sci/R&D Officer - 01/05/2023
Director TitleAgeSince
Chairman 68 30/12/2019
Director/Board Member 74 07/02/2012
Director/Board Member 72 27/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
01/10/26 Sell

Controller/Auditor

-84 0.0001%
21/09/26 Sell

Chief Financial Officer

-1,631 0.0015%
16/09/26 Sell

Chief Operating Officer

-7,330 0.0066%
Change 5-day change 1-year change 3-year change Capi.($)
-5.30%-1.11% - - 1.75TCr
Average -5.30%
Weighted average by Cap. -5.30%

Financials

2026 *2027 *
Net sales 285.25Cr 255.47Cr 234.99Cr 212.92Cr 398Cr 27TCr 405.45Cr 2.8TCr 1.12TCr 14TCr 1.07TCr 1.05TCr 45TCr 300.77Cr 269.37Cr 247.77Cr 224.5Cr 419.65Cr 29TCr 427.51Cr 2.95TCr 1.19TCr 15TCr 1.13TCr 1.1TCr 47TCr
Net income 28Cr 25Cr 23Cr 21Cr 39Cr 2.68TCr 40Cr 277.27Cr 111.3Cr 1.41TCr 105.92Cr 103.67Cr 4.45TCr 35Cr 31Cr 29Cr 26Cr 48Cr 3.29TCr 49Cr 340.1Cr 136.53Cr 1.73TCr 129.92Cr 127.16Cr 5.45TCr
Net Debt 198.53Cr 177.8Cr 163.55Cr 148.19Cr 277Cr 19TCr 282.19Cr 1.95TCr 782.93Cr 9.92TCr 745.05Cr 729.21Cr 31TCr 145.83Cr 130.6Cr 120.14Cr 108.85Cr 203.47Cr 14TCr 207.28Cr 1.43TCr 575.11Cr 7.28TCr 547.28Cr 535.64Cr 23TCr
Projected Income Statement - Annual - Revvity, Inc.
Logo Revvity, Inc.
Revvity, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales break down by family of products as follows: - medical diagnosis equipment (50.1%); - analytical tools and instruments (49.9%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales break down by source of revenue between sales of products (83.7%) and services (16.3%). Net sales are distributed geographically as follows: America (44%), Europe (28.9%) and Asia (27.1%).
Employees
11,000
Date Price Change Volume
30/26/30 $157.00 -5.30% 31,79,985
29/26/29 $165.78 +0.27% 15,29,876
28/26/28 $165.33 +2.14% 21,78,621
27/26/27 $161.86 +0.92% 15,51,691
26/26/26 $160.39 +1.02% 10,89,209
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Revvity, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
157.00USD
Average target price
147.53USD
Spread / Average Target
-6.03%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Revvity, Inc.
  1. Stock Market
  2. Stocks
  3. RVTY Stock